Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297993 · ClinicalTrials.gov registry record
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
A clinical trial of PSC, sponsored by PSC Partners Seeking a Cure.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 16
- Study locations
NCT06297993 is a study of PSC that is actively recruiting participants, run by PSC Partners Seeking a Cure. The registered enrollment target is 2,000 participants. The trial reports 16 study locations across 13 states.
The verdict
NCT06297993, a study of PSC, is actively recruiting participants, sponsored by PSC Partners Seeking a Cure.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
Conditions Studied
Study Locations (16)
California
- UC Davis - Sacramento
- California Pacific Medical Center - San Francisco
- University of California, San Francisco - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Connecticut
- Yale University - New Haven
Florida
- Schiff Center for Liver Diseases / University of Miami - Miami
Indiana
- Indiana University - Indianapolis
Minnesota
- Mayo Clinic - Rochester
Virginia
- Virginia Commonwealth University - Richmond
Alberta
- University of Alberta - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2031-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06297993
The ClinicalTrials.gov registry entry for NCT06297993 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PSC Partners Seeking a Cure, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PSC appearing as the primary indexed condition, and to 0 interventions.
NCT06297993 reports 16 study locations spanning 13 distinct geographic areas - top geographies include California, Massachusetts, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06297993 about?
NCT06297993 is a clinical study titled "Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)". Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
What is the current status of trial NCT06297993?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-05-06. Estimated completion is 2031-01.
What conditions does trial NCT06297993 study?
This clinical trial studies the following conditions: PSC.
Who is sponsoring clinical trial NCT06297993?
This trial is sponsored by PSC Partners Seeking a Cure, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297993 being conducted?
This trial has 16 study locations across California, Connecticut, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PSC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.